for Apr 16, 2019
Multi-faceted #antimicrobialStewardship intervention was successful in reducing broad spectrum antibiotic use by 27% for CAP and was not associated with harm. Well designed stepped-wedged cluster RCT in 9 hospitals in the Netherlands.#ECCMID2019https://t.co/wozOqOdt04 pic.twitter.com/HqR3VZK1fj
— Brad Langford (@BRxAD) April 16, 2019
Did you know the Society of Infectious Diseases Pharmacists has over 1700 members? Many are from outside the US! Join us in our mission to ADVANCE Infectious Diseases pharmacy and LEAD antimicrobial stewardship to OPTIMIZE the care of patients https://t.co/HVH2HtuBcr #ECCMID2019 pic.twitter.com/RD13JpPckH
— SIDP (@SIDPharm) April 16, 2019
Wondering about the future role of IV polymyxins for the treatment of life-threatening CRE infections after the introduction of new safer agents . NEW 🔥 review @BrianTsuji @Keith_S_Kaye @antibioticsmdpi https://t.co/kqztQjsfnr #IDTwitter pic.twitter.com/uy3UA6JM6I
— Antibiotic Steward (@ABsteward) April 16, 2019
BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. - PubMed - NCBI https://t.co/aBCmrN4MNz
— Luis Enrique Alvarez (@LuisEnr80631682) April 16, 2019
NEW🔥 @raseaton66 in @BSACandJAC
— Antibiotic Steward (@ABsteward) April 16, 2019
From ‘OPAT’ to ‘COpAT’: implications of the #OVIVA study for ambulatory management of bone and joint infection. #JACnews #IDTwitter
Sorry #ECCMID2019 https://t.co/n43OhAtvaQ pic.twitter.com/VlhIpyk95J
New online, 2 articles on #EbolaDRC. (1) 2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo https://t.co/qDGOvj7opR
— The Lancet Infectious Diseases (@TheLancetInfDis) April 16, 2019
From ‘OPAT’ to ‘COpAT’ - Putting OVIVA study into practice @BSACandJAC @eopat @MGilchrist123 https://t.co/vQmF66wHeO
— andrew seaton (@raseaton66) April 16, 2019
The association between adherence to national #antibiotic guidelines and mortality, readmission and length of stay in hospital inpatients: a Norwegian multicentre, observational cohort study https://t.co/Df885p9kbt #aricjournal @s_wathne @BSkodvin @e9385730d75a4d1
— Esmita Charani (@e_charani) April 16, 2019
New @TheLancet: Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study https://t.co/sqDxwSP3dU
— The Lancet Infectious Diseases (@TheLancetInfDis) April 16, 2019
Two phage-encoded receptors, like their bacterial counterparts, bind to the quorum sensing molecule produced by the host bacterium, suggesting that phages can “listen in” on their bacterial hosts @mbiojournal https://t.co/KS4xd2BQxk pic.twitter.com/MEnhTBJtVA
— ASM (@ASMicrobiology) April 16, 2019
Read our press release to learn more about this exciting new development for #ResistanceGuidedTherapy
— SpeeDx (@speedx) April 16, 2019
Mycoplasma genitalium & macrolide resistance markers in a FleXible Cartridge coming soon! https://t.co/UqywVKUgrF#Mgen #diagnostics #antimicrobialstewardship #partnership
Hopeful news: Researchers successfully programmed a bacterial genetic structure to make it capable of specifically killing multiple #antibiotic-resistant bacteria w/o also destroying bacteria beneficial to the body. https://t.co/KxC1wuLfI3 #antibiotics #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) April 16, 2019
Current dosing regimens for ciprofloxacin in renally-impaired patients may result in sub-therapeutic levels, particularly at MICs of 0.125 mg/L and higherhttps://t.co/ihkuIerooy #ECCMID2019 pic.twitter.com/gzymJg5DsO
— Brad Langford (@BRxAD) April 16, 2019
Prospective audit/feedback form ⬆️guideline adherence for SAB led by Holly Hoang
— UofA Infectious Diseases (@UofA_ID) April 16, 2019
Impact of an Unsolicited, Standardized Form–Based Antimicrobial Stewardship Intervention to Improve Guideline Adherence in the Management of Staphylococcus aureus Bacteremia https://t.co/uYVWnwRcmC
100 Years of Fighting Pandemic Influenza: 1918/19–2018/19. The Journal of Infectious Diseases explores making universal flu vaccines and predicting future epidemics 👉https://t.co/XYwrsU0oxE pic.twitter.com/BUFmPObd7W
— CEPI (@CEPIvaccines) April 16, 2019
PIDJ: A population-based study of Acute Flaccid Myelitis #AFM incidence, risk factors & outcomes in the Kaiser CA network https://t.co/tR6ATPU1XM
— Kevin Messacar (@kmess44) April 16, 2019
Real time CPOE conversational tools are a feasible approach to deliver #AntimicrobialStewardship
— Brad Langford (@BRxAD) April 16, 2019
prospective audit and feedback recommendations. Nice work by Sameer Elsayed and @RitaDhami!https://t.co/4GC8BlRhp6 #ECCMID2019 pic.twitter.com/NPXdNheN37
Evaluation of more than 7,500 isolates to predict phenotypic resistance to several antibiotic classes through detection of resistance genes using a high-throughput multiplex PCR test and statistical modeling #AACJournal https://t.co/rT8B6CjZ6N pic.twitter.com/3RRDMqRq5K
— ASM (@ASMicrobiology) April 16, 2019
Kenneth Iregbu Consultant Clinical Microbiologist Nigeria at #ECCMID2019 "One of biggest challenges of the #AMS issue is not having the capacity to gather information. We have been able to do so now using the Global-PPS platform https://t.co/HVwEUMo1kq #AntimicrobialStewardship pic.twitter.com/UOYgI3PamA
— bioMérieux (@biomerieux) April 16, 2019
This is indeed not good news. This highlights how we need robust and meaningful #antibiotic stewardship programs in human and animal settings put in place now -- all over the globe -- before it's too late. https://t.co/qY7W7UpJYz #AntibioticResistance #ECCMID2019
— Battle Superbugs (@battlesuperbugs) April 16, 2019
A @WHO study that quantifies GDP productivity losses associated with Disability-Adjusted Life Year (DALY) shows: ✓In Africa 37% of total productivity losses are due to #NCDs ✓27% to infectious diseases like #AIDS, TB, malaria. https://t.co/s4473dnaDw @gavi @theGFF @GlobalFund
— Gates Africa (@GatesAfrica) April 16, 2019
🤔🧼✋🏼🤒
— Bug Pharmacist (@IDstewardship) April 16, 2019
Should patient hand hygiene be something we are more concerned with?
New article in CID with @Keith_S_Kaye 📲 https://t.co/26ulQX9B2P #InfectionControl #WashYourHands pic.twitter.com/DJZTNoPVIP
Hey, come have a beer and hear me talk about science stuff! I'll have pretty pictures of bacteria and gloomy stories of how they're plotting to kill us all.....May 20 at the Norman Hotel.
— Mark Blaskovich (@mark_blaskovich) April 16, 2019
Medical detectives 20 May #Brisbane @pintofscienceAU #pint19 https://t.co/wCaUpKyfvc
Funding call launching today: NIHR’s Policy Research Programme is launching a call on the implementation and effectiveness of educational interventions in improving behaviour on antimicrobial stewardship. Find out more and apply online: https://t.co/UudUoJJYoh pic.twitter.com/N6wj8I7IHK
— NIHR Research (@OfficialNIHR) April 16, 2019
Important negative RCT of combo Rx (vanco or dapto vs same with fluclox or cefaz x 7d) for MRSA bacteremia.
— Paul Sax (@PaulSaxMD) April 16, 2019
Mortality numerically higher in combo arm with more renal adverse events.
How about 3-arm, RCT?
-vanco or dapto (SOC, investigator choice)
-ceftaroline
-dapto/ceftaroline https://t.co/OUFOAH0yWH
#latebreaker The CAP-PACT cluster randomised trial showed that a #antimicrobialstewardship intervention in community-acquired pneumonia reduced broad-spectrum antibiotic use by 27% and was non-inferior regarding 90-day mortality. #ECCMID2019 @MarcBonten @schweitzer_va pic.twitter.com/IZ3eaPpOLe
— Trainee Association of ESCMID (@TAEscmid) April 16, 2019
COME AND DO A PHD WITH ME & @erik_malmqvist in practical philosophy on the #bioethics of #AntibioticResistance and the environment!
— Christian Munthe (@christianmunthe) April 16, 2019
DEADLINE: April 30!#philosophy #publichealth #environment #AMR #ABR #ethics #AntimicrobialResistance #healthcare #healthhttps://t.co/4Jq58SyXvD
Sad news for fight against superbugs today as @achaogen files for bankruptcy – the latest example of the broken market for #antibiotic research and development. https://t.co/cVjnJpwUzT https://t.co/ZgSLszyMKx
— Save Antibiotics (@saveantibiotics) April 16, 2019
Top Influencers of #ECCMID2019 👉 @jdelpoleo @MicrobLog_me_uk @aliciad3 @ABsteward @TAEscmid @ESCMID https://t.co/OReWbZZCTA via @symplur
— Antibiotic Steward (@ABsteward) April 16, 2019
#CwPAMS - exciting - two teams are currently in Uganda. We'll be following the @Buckshealthcare @MakSPA @Linda4Gibson @DavidMusoke14 @fredkitutu @WinterJody @ClaireBrandish1 team via Instagram - https://t.co/opi8C5zkkB #AntibioticGuardian champions cc @CW_Pharmacists @THETlinks
— Diane Ashiru, PhD (@DrDianeAshiru) April 16, 2019
Measles cases are up nearly 300% from last year. This is a global crisis (opinion by @unicefchief and @DrTedros)
— Microbes&Infection (@MicrobesInfect) April 16, 2019
Cases have soared across the world, including in places where #measles had previously been eliminated.https://t.co/VacW6C6BBi
Measles cases are up worldwide from this time last year, with more than 112,000 cases being reported by 170 countries. https://t.co/cGpQtcCXR8 @SciSpeaksBlog #measlesoutbreak #VaccinesWork
— IDSA (@IDSAInfo) April 16, 2019
With more #measles cases popping up around the globe be sure to check out our #Guide chapter to update yourself on the most up-to-date practices in #InfectionControl and Prevention. #IPC #InfectiousDiseases https://t.co/VP9sTny0Vg pic.twitter.com/91rFTLbuUf
— ISID (@ISID_org) April 16, 2019
New @JBacteriology commentary: A stringent analysis of polyphosphate dynamics in E. coli https://t.co/wFukZ7gZuk - comment on https://t.co/BXr9UlD4OS
— ASM (@ASMicrobiology) April 16, 2019
An often forgotten side of the #antibiotic resistance crisis. @CDDEP: "Lack of access to #antibiotics kills more people currently than does antibiotic resistance, but we have not had a good handle on why these barriers are created." https://t.co/n4RJPxU7b2
— Battle Superbugs (@battlesuperbugs) April 16, 2019
Valentijn Schweitzer graduated in 2014 and completed an MSc degree in Epidemiology in 2018. He is working as a PhD candidate on the subject of Antimicrobial Stewardship and Community-acquired Pneumonia. Read more here: https://t.co/iJSbjPH5sx pic.twitter.com/f90uxv8YRt
— ICPIC (@ICPIC_meeting) April 16, 2019
Excited to participate in #CCCAS - Clinician Champions in Comprehensive Abx Stewardship - and would encourage fellow clinicians interested in decreasing abx use in agriculture to take a look!https://t.co/eQmd0ajKKK@PIDSociety @sharpsgroup @uspirg @HCWithoutHarm @matthewwell
— Sujit Suchindran (@sujitsuchindran) April 16, 2019
Marin Kollef discusses the ASPECT-NP study of TOL-TAZ vs MEM with @Contagion_Live at #ECCMID2019 . Patients were pretty ill in the study. Abstract here: https://t.co/bYXI1dcDAb@SIDPharm @accpinfdprn https://t.co/1Dtr8IF7Qs
— Jason Gallagher (@JGPharmD) April 16, 2019
Molecular-Characterization of Methicillin-Resistance Staphylococcus aureus (MRSA) from Different Tertiary Care Hospitals in Bangladesh. https://t.co/sYCujVX2VZ
— AntibioticResistance (@AntibioticResis) April 16, 2019
Rapid #antibiotic susceptibility testing decreases time to results by ~2 days and facilitates earlier therapeutic changes. #AMR #antimicrobialstewardship #ECCMID2019 pic.twitter.com/lYvga2OdCS
— Trainee Association of ESCMID (@TAEscmid) April 16, 2019
New @TheLancetHIV: Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial https://t.co/PXwCGwYqhm
— The Lancet Infectious Diseases (@TheLancetInfDis) April 16, 2019
For pharmacy academics looking for PCOA role as a predictor (or potential) for NAPLEX, see in @TheAJPE this issue. https://t.co/PUDT0heaDK #PCOA #NAPLEX pic.twitter.com/8egrHNqLCK
— Brandon Bookstaver (@BBookstaver_USC) April 16, 2019
“Antibiotic-resistant microbes, known as superbugs, are pinballing around the world, killing hundreds of thousands of people every year,” writes @DrMattMcCarthy for @nytimesopinion. https://t.co/ghhXSKqvJj
— Save Antibiotics (@saveantibiotics) April 16, 2019
Urge Congress to maintain funding for the programs that fight #antibioticresistance: https://t.co/UogB3ZOYHZ
— Save Antibiotics (@saveantibiotics) April 16, 2019
+ Comment: Preparing for the next #Ebola outbreak: in-country genomic capacity in Africa https://t.co/07XKafUv3m
— The Lancet Infectious Diseases (@TheLancetInfDis) April 16, 2019
New infectious threats and new antimicrobial solutions...@IMIBirmingham in the spotlight in today’s @khaleejtimes:https://t.co/PSB6XlEW8w
— IMIBirmingham (@IMIBirmingham) April 16, 2019
(slightly scary guy in the photo, though - just ignore him and read the text 😉)
Antimicrobial resistance greatly impacts outcomes for COPD patients, & our team has developed this dashboard, a real-time clinical data visualization tool, to help you deliver excellence in antimicrobial stewardship as it relates to COPD: https://t.co/ORAJcQSdsw #antibiotic pic.twitter.com/27iRtXSzLv
— Think Research (@TRChealth) April 16, 2019
In this guest editorial, Bernhard L. “Bud” Wiedermann, MD, MA, a pediatric infectious disease physician at @childrenshealth, discusses the dangers associated w/ the resurgence of #vaccine-preventable diseases: https://t.co/iMR6WUTt28 #measles
— ID in Children (@IDinChildren) April 16, 2019
CAMERA2 trial (RCT evaluating monotx vs. combination tx (standard of care plus beta-lactam) for MRSA BSI: No benefit in death/complications but NNH 4.7 for AKI in combo arm.
— Brad Langford (@BRxAD) April 16, 2019
Via: @syctong @davidantibiotic @Guru_JoshD @TheDohertyInst@MenziesResearch #ECCMID2019 #camera2trial pic.twitter.com/u5hsBYBvhy
Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO) https://t.co/4zlqTN849f
— Etelvina Ferreira (@etelvinaferr) April 16, 2019
Preparing for the next #Ebola outbreak: in-country genomic capacity in Africa.
— ɪᴀɴ ᴍ ᴍᴀᴄᴋᴀʏ, ᴘʜᴅ 🦠🧬🥼🦟 (@MackayIM) April 16, 2019
"To prepare for the next EVD outbreak, we advocate the establishment of national and regional hubs of excellence in infectious diseases genomics.."https://t.co/9y89WmdZWx
Sad news for a great team developing much needed medicines. ...#amr #AntibioticResistance https://t.co/gaRlSMQiCG via @Shareaholic
— Mark Blaskovich (@mark_blaskovich) April 16, 2019
(2) Medical countermeasures during the 2018 #Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo https://t.co/wKo4t5CyhG
— The Lancet Infectious Diseases (@TheLancetInfDis) April 16, 2019
Achaogen bankruptcy raises worry over #antibiotic pipeline https://t.co/5wJxKVYQ0i @achaogen #AMR #AntibioticStewardship #AntibioticResistance pic.twitter.com/7inklIZRP1
— CIDRAP (@CIDRAP) April 16, 2019
Tobramycin exposure in obese patients is best predicted by renal function (rather than weight), a dosing nomogram as shown below is recommended. This does not appear to be a class effect. #ECCMID2019https://t.co/KEKFlI1f1b pic.twitter.com/OfCZzw15xD
— Brad Langford (@BRxAD) April 16, 2019
Top Influencers of #ECCMID2019 👉 @TAEscmid @ESCMID @ErinMcCreary @TheLancetInfDis @ABsteward @eccmid https://t.co/OReWbZZCTA via @symplur
— Antibiotic Steward (@ABsteward) April 16, 2019
Great thread by @EricMacyMD#CAMERA2 #latebreakers
— Antibiotic Steward (@ABsteward) April 16, 2019
More questions than answers!
Largest RCT to date of pts w MRSA bacteraemia
Combination Antibiotic therapy for MRSA bacteraemia@Guru_JoshD, @davidantibiotic, @paul_mical, @syctong @ASIDANZ #ECCMID2019 #IDTwitter #IDMedEd https://t.co/4hdBauKDTM
Low risk = no hx of anaphylaxis, index reaction > 1 year ago, and/or unknown index drug. NPV of the history is similar to skin testing, only 1% skin test + and 0.6% DPT+. Identifying Low-risk Beta-Lactam allergy Patients in a UK Tertiary Centre https://t.co/d1qIYeEHVC
— Eric Macy (@EricMacyMD) April 16, 2019
Microbiology <-> Infectious Diseases sinergy provides great value @HaraldSeifert Cantón’s knot goes viral @RafaMCanton ;-)https://t.co/mINF41N1no https://t.co/zkux6WSYt5
— José Ramón Paño (@joserrapa) April 16, 2019
When discussing & developing interventions to curb #AntibioticResistance, it's important to consider the constraints, especially in #LMICs. The problems exist all over the field of innovation, here, we focus on diagnostics for illustration. ▶️▶️▶️ https://t.co/9ijq2e6xXT
— ReAct Action on ABR (@reactgroup) April 16, 2019
As the number of new measles cases continues at record pace, researchers warn of the infection’s longer-term implications. https://t.co/5W4pnLW02M #VaccinesWork #measlesoutbreak
— IDSA (@IDSAInfo) April 16, 2019
I enrolled in the #OpenWHO course Antimicrobial Stewardship: A competency-based approach https://t.co/EBuO1DnEr9
— Collins D. Pambo Jaguga (@CJaguga) April 16, 2019
Metabolic exchanges may allow different microbes to specialize in distinct tasks and evolve division of labor; understanding these divisions may help design synthetic microbial communities @mSystemsJ https://t.co/GUX0oPD59L pic.twitter.com/06gXEKCbmE
— ASM (@ASMicrobiology) April 16, 2019
#SocialSciences research for #Ebola response in #DRC & neighboring countries featured on the @WHO website 👉 https://t.co/b1On1eSxe6. @SonarGlobalEU supports @WHO & others for their work on #InfectiousDiseases & #outbreaks. pic.twitter.com/f6IbKdjgZc
— Sonar-Global (@SonarGlobalEU) April 16, 2019
Molecular rapid diagnostic tests on positive blood cultures positively impacts patient outcomes if #AntimicrobialStewardship is involved @HaraldSeifert #ECCMID@GEIRAS_SEIMC @ESGAP_ABS @SEIMC_ @RafaMCanton @pacificjulio @GemaraSeimc pic.twitter.com/lSiGb7IgAJ
— José Ramón Paño (@joserrapa) April 16, 2019
New @mbiojournal minireview: mechanisms, detection, and relevance of protein acetylation in prokaryotes https://t.co/K2YtYUIjFu pic.twitter.com/zs0hHCcGwY
— ASM (@ASMicrobiology) April 16, 2019
KfW and @BNITM_de are supporting the East African Community with the aim of identifying outbreaks of dangerous infectious diseases at an early stage. The goal is to establish a network of #mobileLaboratories🧪. https://t.co/rlE3YljH5r@BMZ_Bund #africa #health pic.twitter.com/QGP0sJKA3O
— KfW (@KfWpress) April 16, 2019
Not good: A gene that enables bacteria to be highly resistant to linezolid (an #antibiotic used as a last resort for treating infections in people), found in bacterial samples from cats & a dog at small-animal hospital in the #UK for the first time. https://t.co/wnA8ImoNTF
— Battle Superbugs (@battlesuperbugs) April 16, 2019
So proud to see pharmacists leading/co-leading on #CwPAMS a global health project to support antimicrobial stewardship and tackle AMR in Ghana, Uganda and Tanzania. Thank you for being part of the partnership @MakSPH cc @THETlinks @CW_Pharmacists @keithridge1 https://t.co/qyg6rYF0wj
— Diane Ashiru, PhD (@DrDianeAshiru) April 16, 2019
The study was randomized. Why did the comb arm had more AKI? How would u explain that? Likely due to fluclox to me rather than cefazolin. We already know that antistaph PCN can cause nephrotoxicity (more than cefazolin)https://t.co/p6Bk1LCyaW…
— Antibiotic Tweets (@khalideljaaly) April 16, 2019
“The set of thing that are beneficial overlaps only in part with the set of things that are profitable.” -@michalrozworski @Leigh_Phillips
— ReedSiemieniuk. (@RSiemieniuk) April 16, 2019
We urgently need a publicly owned pharmaceutical company.$AKAO #Achaogen #AntibioticResistance #AntimicrobialStewardship #cdnpoli https://t.co/QqIAYMwCFZ
Dr. David Kimberlin, Professor/Co-Director, Division of Pediatric Infectious Diseases at Children's and UAB is featured on the front page of USA Today discussing the importance of vaccinations. https://t.co/6edSWfWyvT
— ChildrensAL (@ChildrensAL) April 16, 2019
#DYK? more than 75% of emerging infectious diseases are of animal origin, and foodborne diseases and AMR are increasingly emerging at the human-animal interface. @FAO working for #OneHealth, #animalHealth & #ZeroHunger. Learn more here:https://t.co/U8NSDov1Xr pic.twitter.com/t31AjilwD2
— FAO Asia Pacific (@FAOAsiaPacific) April 16, 2019
I'm hoping @NCDCgov will work with hospitals majorly with clinical pharmacist to develop Antimicrobial stewardship policy. ..The world are on AMS to reduce antimicrobial resistance.. https://t.co/7mlRr3r4Zz
— Pharm. Hazeeb Ibrahim Opeyemi (@IbrahimAjijola) April 16, 2019
Thanks to the @ESCMID team for such a fruitful #ECCMID2019. And thanks to the president @jesusrbano for his commitment with the fight against #AMR! We are looking forward to meet again next year in Paris. #antimicrobialresistance #antimicrobialstewardship pic.twitter.com/0K0IeGh2MV
— EU-JAMRAI (@EUjamrai) April 16, 2019
Today, our SVP of Research, Frank DeRosa and @sanofipasteur's Head Of External R&D, Mark Parrington, will discuss our ongoing collaboration focused on #mRNA vaccines for #infectiousdiseases at the World Vaccine Congress: https://t.co/hKWzLCPPDi #WVCUSA #WVC2019 @vaccinenation pic.twitter.com/lbSMkNn9xm
— TranslateBio (@TranslateBio) April 16, 2019
I like this idea. fast...
— Tim Frenzel (@horstie) April 16, 2019
Using Machine Learning To Predict Antimicrobial MICs and Associated Genomic Features for Nontyphoidal Salmonella | Journal of Clinical Microbiology#MachineLearning #AntimicrobialResistance #AntimicrobialStewardship #ECCMID2019
https://t.co/r4vlEIIzMX
Well it's goodbye from the on site bioMérieux team at #ECCMID2019 Amsterdam. We enjoyed meeing participants & exchanging on #AntimicrobialStewardship, innovations and needs. We look forward to seeing you all in 1 year from now in Paris! #DiagnosticsIsPower pic.twitter.com/REImw47MQQ
— bioMérieux (@biomerieux) April 16, 2019
$CFRX Presents additional Positive Data from the Phase 2 Trial of Exebacase (Lysin CF-301) at the 29th European Congress of Clinical Microbiology and Infectious Diseases (@ECCMID) https://t.co/JyJ1phDmaA
— Prof. Dollar (@Prof_Dollar) April 16, 2019
After clean water, vaccines are the most effective way to prevent infectious diseases. From 2000 to 2015 it is estimated that the Hib vaccine prevented 1.2 million deaths. https://t.co/c10LI0C9ws #VaccinesWork pic.twitter.com/Ht5jtv6Dyh
— COMOmeningitis (@COMOmeningitis) April 16, 2019
Very important article by @GrogsGamut https://t.co/2BMwJOajVm #inequality
— Trent 💊🆔 (@trentyarwood) April 16, 2019
Gender parity in infectious diseases https://t.co/91s9ek8Ffk
— Harvard CFAR (@HarvardCFAR) April 16, 2019
While challenges around #vaccines differ worldwide, the importance of building trust within communities is universal. https://t.co/AZRnZsoEzS @sciam #VaccinesWork #measlesoutbreak
— IDSA (@IDSAInfo) April 16, 2019
A new report explores the ROI of #clinicalsurveillance, and importantly, how #hospitals can maximize that ROI for #healthcare providers. #patientsafety #infectioncontrol #antimicrobialstewardship https://t.co/n0BWOiUXHi pic.twitter.com/pod4TlewNq
— VigiLanz (@vigilanzcorp) April 16, 2019
Dr Aoife Fleming presenting some interesting Irish-based research on antimicrobial stewardship from @UCC - well done to all involved! https://t.co/OfjawoxZun
— PharmCareUCC (@PharmCareUCC) April 16, 2019
Antibiotic Susceptibility Pattern of Bacteria Isolated From Various Specimens of Patients with Hematological Malignancy. https://t.co/YVnPRv0CXH
— AntibioticResistance (@AntibioticResis) April 16, 2019
ADR rates for iohexol (0.24%) and iodixamol (0.27%), the most commonly used in the USA, are among the lowest for all ICM.
— Eric Macy (@EricMacyMD) April 16, 2019
Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database https://t.co/S3OdBtNitn
📢 New Postdoc Alert! 📢The Wilcox Lab (@kswilcox) is looking for a #postdoc! Help work on basic #epilepsy research and therapy development in the @uofupharmacy. https://t.co/brvmi7mXmP #ECRchat #PhdChat #AcademicTwitter #ScienceJobs #Research #Neuroscience pic.twitter.com/Fy4hALgH6H
— UofU3i (@UofU3i) April 16, 2019
Created by Cameron Forbes. Last updated April 19, 2019 at 07:34 EST.